Viralytics Limited DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

2 News #PharmaBuzz

media
2 News #PharmaBuzz

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Viralytics is focused on the development and commercialisation of oncolytic immunotherapies that harness the power of certain viruses to preferentially infect and kill cancer cells. Our lead product candidate is CAVATAK®, a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21, now being evaluated in multiple clinical trials. CAVATAK binds to specific receptor proteins highly expressed on a range of tumour cell types, and acts to destroy local as well as metastatic cancer cells through cell lysis and the potential generation of a specific immune response against the cancer cells.